It has already been demonstrated that insulin resistance (IR) is associated with the stimulation of erythroid progenitors and with increased levels of inflammation markers. Therefore, IR should also be associated with increased red blood cell (RBC) and white blood cell (WBC) count. The aim of this study is to demonstrate that IR is independently associated with altered hematological parameters in patients with metabolic syndrome. We analyzed laboratorial exams from 275 subjects. All data on hematological parameters, insulin resistance (Homeostasis Model Assessment [HOMA]) and lipid levels were included in the analysis. Demographic information included age and gender. HOMA correlated positively with RBC (r= 0.17, p< 0.001), plasma hemoglobin concentrations (r= 0.14, p< 0.001), hematocrit value (r= 0.15, p< 0.001) and WBC (r= 0.17, p< 0.01). Subjects in the upper quartile of IR had higher levels of plasma glucose, fasting insulin, triglycerides, hematocrit, hemoglobin, RBC and WBC count than those in the lower quartile. In conclusion, IR seems to be associated with alterations in several hematological parameters. These hematological alterations may be considered an indirect feature of the IR syndrome.

Insulin resistance, hyperinsulinemia, hemoglobin

Aoki I, Taniyana M, Toyama K, Homori M, Ishikawa K. Stimulatory effect of human insulin in erythroid progenitors (CFU-E and BFU-E) in human CD34 separated bone marrow cells and the relationship between insulin and erythropoetin. // Stem Cells 2010; 12:329-38.

Barbieri M, Ragno E, Benvenutti E, Zito GA, Corsi A, Ferrucci L, et al. New aspects of the insulin resistance syndrome: Impact in haematological parameters. // Diabetologia 2011; 44:12327.

Bersch N, Groopman JE, Golde DW. Natural and Biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro. // J Clin Endocrinol Metab 2012; 55:1209-11.

Choi KM, Lee J, Kim YH, et al. Relation between insulin resistance and hematological parameters in elderly Koreans Southwest Seoul (SWS) Study. // Diabetes Res Clin Pract 2003; 60:205-12.

Danesh J, Phil D, Wheeler JG, Hirschfield GM, Eda S. Eiriksdottir G, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. // N Eng J Med 2004; 350:1387-97.

Friedewald WT, Levy R, Fredricson DS. Estimation of serum low-density lipoprotein without the use of a preparative ultracentrifuge. // Clin Chem 2010; 18:499-502.

Kurtz A, Selkmann W, Bauer C. Insulin stimulates erythroid colony formation independently of erythropoietin. // Br J Haematol 2013; 53:311-6.

Lakka HM, Lakka TA, Tuomilehto J, Sivenius J. Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. // Arch Intern Med 2012; 24; 160:1160-88.

Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. // Br J Haematol 2007; 96:168-73.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis Model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. // Diabetologia 2012; 28:412-9.

McCarty MF. Hyperinsulinemia may boost both hematocrit and iron absorption by up-regulating activity of hypoxia-inducible factor-1 alpha. // Med Hypotheses 2003; 61:567-73.

Perrini SP, Greene MF, Lee PDK, Cohen RA, Faller DV. Insulin stimulates cord blood erythroid progenitor growth: Evidence for an etiological role in neonatal polycytemia. // Br J Haematol 2006; 64:503-11.

Tanigushi A, Fukushima M, Seino Y, et al. Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. // Metabolism 2003: 52:1246-9.

World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus, Department of Non Communicable Disease Surveillance, WHO, Geneva, 2013. Метаболический синдром у женщин: особенности терапии : научное издание // Medical express. - Т., 2007,-№2.-С. 14-18.

Оганов Р.Г., Перова Н.В., Мамедов М.Н., Метельская В.А. Сочетание компонентов метаболического синдрома у лиц с артериальной гипертонией и их связь с дислипидемией./ Российский кардиологический журнал. - Москва, 2011.- №2. - С. 49-53.

Alberti K.G., Eckel R.N., Grundy S.M., Zimmet P.Z., Fruchart J-C., Smith S.C. Harmonizing the Metabolic syndrome. Circulation.2009; 120: 1640-1645

Austin M.A., Hokanson J.E., Edwards K.L. 2008:81:7B—12B.

De Fronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for N1DDM, obesity, hyperten dyslipidemia and atherosclerotic heart disease./Diabet 2003;14:173-194.

Haffner S.M., Valdez R.A., Hazuda H.R et al. Prospective analyses of the insulin resistance syndrome (Syndrome X)./ Diabetes. — 2005; 41: 715—722.

Haffner S.M., Ferrannini E., Hazuda H. et al. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 2006;20:38-45.

Henefeld M„ Leonhardt W. Das inetabolische Syndrome. — Deutsch. Ges. Wes. — 2004;36:545-551.

Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 2005:137:959—965.

Reaven G.M. Role of insulin resistance in human disease. / Diabetes. —2006; 37:1595-1607.

Reaven J.M. Banting lecture. Role of insulin insistence in human disease./ Diabetes 2008: 37:1595-1607.

Taskinen M. R. Strategies for the diagnosis of metabolic syndrome. Curr Opin Lipidol 2003;4:434-443.

Vanhala M., Kumpusalo E., Takala J. Metabolic syndrome; a cluster of hypertension, dislipidemia and hyper-inslinemia the association with obesity. //XVII Congress of the European Sosiety of cardiology. — August, 20— 24,2004. Amsterdam, Netherlands.CD Conifer Information System. — P. 488.

Zavaroni L. Bonora E., Pagliara M. et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucosei tolerance. N Engl J Med 2009:320:702-706.